|
About the Frequently Asked Questions category
|
|
0
|
73
|
8 March 2021
|
|
Why does the Open Targets Genetics portal display partial L2G scores on Locus pages when there is no evidence of colocalization?
|
|
0
|
58
|
3 November 2021
|
|
How does the Platform display direct and indirect evidence?
|
|
3
|
69
|
8 September 2021
|
|
Why are beta and odds ratios not always displayed in the Open Targets Genetics Portal?
|
|
0
|
45
|
26 August 2021
|
|
In the “tag variants” section of variant summary pages in the Open Targets Genetics Portal, why do some SNPs have a posterior probability and others don’t?
|
|
0
|
35
|
23 August 2021
|
|
How can I download data from the Open Targets Genetics Portal?
|
|
0
|
90
|
4 August 2021
|
|
How often is the Open Targets Genetics portal updated?
|
|
0
|
39
|
29 July 2021
|
|
In the Open Targets Genetics Portal, what is the “credible set overlap”?
|
|
0
|
48
|
22 July 2021
|
|
How to interpret Variant-to-Gene (V2G) and Locus-to-Gene (L2G) scores in the Open Targets Genetics Portal
|
|
0
|
67
|
19 July 2021
|
|
What fine-mapping and colocalisation software does the Open Targets Genetics Portal use?
|
|
0
|
46
|
14 July 2021
|
|
How are tag variants identified in the Open Targets Genetics Portal?
|
|
0
|
53
|
12 July 2021
|
|
How are UK Biobank study traits identified in the Genetics Portal?
|
|
0
|
61
|
7 July 2021
|
|
What is the difference between the Open Targets Platform and the Open Targets Genetics Portal?
|
|
0
|
78
|
16 June 2021
|
|
What happened to the batch search functionality?
|
|
7
|
300
|
28 June 2021
|
|
Score values from Disease->Target vs. Target->Disease
|
|
3
|
118
|
25 June 2021
|
|
Batch query for biomarker prioritization
|
|
1
|
165
|
13 May 2021
|
|
Why doesn't the Platform distinguish between diseases and phenotypes?
|
|
0
|
84
|
6 May 2021
|
|
What ontology is used for disease and phenotype terms?
|
|
0
|
91
|
8 March 2021
|
|
How can I view diseases and phenotypes associated with a given target?
|
|
0
|
94
|
8 March 2021
|
